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Balloon pulmonary valvuloplasty was attempted in 67 patients 
with tetralogy of Fallot at a median age of 5 months (range 0.03 to 
52 months) for relief of cyanosis. In three patients, the valve could 
not be crossed and an aortopulmonary shunt was performed. In 
35 patients, follow-up angiography was performed 3 to 30 months 
(average 12) after valvuloplasty. In 24 of these 35 patients (group 
A), the stenosis had been adequately palliated by valvuloplasty; 
the other 11 patients (group B) had required an aortopulmonary 
shunt 1 month (range 0 to 3 months) after valvuloplasty. The two 
groups were similar (p > 0.1) with respect to age at valvuloplasty, 
pulmonary anulus diameter, ratio of pulmonary artery to de-
scending aorta diameter before valvuloplasty and interval to 
follow-up angiography. In contrast to patients in group B, patients 
in group A had a significant immediate improvement in systemic 
arterial oxygen saturation (p < 0.01) and a significant increase in 
Balloon dilation of the pulmonary valve is now accepted as 
a safe and effective procedure for the relief of congenital 
pulmonary valve stenosis, both in infants and in older 
children (1-3). Although stenosis at the pulmonary valve 
level often forms an important component of the right 
ventricular outflow tract obstruction in tetralogy of Fallot, 
little has yet been reported (4,5) about the efficacy of balloon 
dilation of the pulmonary valve in this lesion. No long-term 
study of the effect of this procedure in relieving cyanosis or 
on subsequent growth of the pulmonary anulus and branch 
pulmonary arteries exists. This is in part due to the good 
results obtained with palliative aortopulmonary shunt pro-
cedures (6-9) and to the increased preference of some 
centers for primary correction of this lesion in infancy 
(10-12). However, shunt procedures are associated with a 
definite mortality rate and complications include shunt fail-
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pulmonary anulus diameter at follow-up angiography (p < 0.001). 
The growth of the branch pulmonary arteries was similar (p > 
0.1) in the two groups. 
Among 42 patients who have had surgical correction, a trans-
annular patch for right ventricular outflow tract reconstruction 
was used in 27 (64%); there was no dift'erence between groups A 
and B with respect to its use. Eight patients died (three after 
repair) and death could not be directly attributed to valvuloplasty 
in any. 
Balloon valvuloplasty promotes growth of the pulmonary valve 
anulus and pulmonary arteries and is a useful alternative to an 
aortopulmonary shunt in patients with small pulmonary arteries 
or associated complex intracardiac defects. 
(J Am Coll CardioI1990;18:159-65) 
ure (8,9), distortion of the pulmonary arteries (13) and 
pulmonary hypertension (14). 
Correction of tetralogy of Fallot in infants usually neces-
sitates use of a transannular patch in the right ventricular 
outflow tract (10,11), which has been regarded as an addi-
tional risk factor for operative death (15). Placement of a 
transannular patch inevitably produces pulmonary regurgi-
tation (16), and the long-term effects of this on the right 
ventricle are still unclear (16-19). In many centers, there-
fore, elective staged repair of the lesion is routinely per-
formed with a good outcome (20). 
Balloon pulmonary valvuloplasty is an alternative to 
aortopulmonary shunts for the relief of cyanosis. This report 
examines the effect of this procedure on relief of symptoms 
and on growth of the pulmonary anulus and branch pulmo-
nary arteries. 
Methods 
Study patients. Over a 72 month period up to December 
1989, balloon pulmonary valvuloplasty was attempted in 67 
patients with a primary diagnosis of tetralogy of Fallot (58 
patients), tetralogy of Fallot with a complete atrioventricular 
(A V) septal defect (7 patients), A V septal defect and aortic 
valve stenosis (1 patient) or a disconnected left pulmonary 
0735-1097/911$3.50 
160 SREERAM ET AL. 
BALLOON VALVULOPLASTY IN TETRALOGY OF FALLOT 
artery and mUltiple aortopulmonary collateral arteries (l 
patient). The patients ranged in age from 0.03 to 52 months 
(median 5) at the time of initial balloon dilation. The indica-
tions for the procedure were persistent central cyanosis or 
recurrent severe cyanotic spells; all were patients in whom 
intervention was considered necessary. In 65 patients, val-
vuloplasty was attempted as the primary palliative proce-
dure; 2 patients had undergone a prior aortopulmonary shunt 
procedure without relief of symptoms. Informed consent 
from the parents was obtained before every procedure and 
the study protocol was approved by the hospital's Commit-
tee on Human Research. 
Pulmonary valvuloplasty. All but six of the pulmonary 
valvuloplasty procedures were performed under general 
anesthesia. Parenteral morphine was routinely administered 
as premedication to lessen the probability of cyanotic spells 
during valvuloplasty. Propranolol was not given routinely 
during the procedure. A standard technique as described for 
dilation of stenotic pulmonary valves (2,3) was used. After 
right ventricular angiography, the maximal balloon size was 
chosen on the basis of the diameter of the pulmonary valve 
anulus (as measured from the hinge points of the leaflets in 
the anteroposterior projection) and the narrowest portion of 
the pulmonary artery outflow tract. A guide wire was posi-
tioned across the pulmonary valve by means of an end-hole 
catheter; the catheter was then withdrawn, leaving the guide 
wire in place. The balloon catheter was advanced over the 
guide wire and positioned so that the midpoint of the balloon 
was across the pulmonary valve anulus. The balloon was 
inflated with use of diluted contrast medium until the waist 
produced by the stenotic pulmonary valve was abolished and 
then was immediately deflated. When inflation of the balloon 
did not produce a waist, a larger balloon was used. The 
number of inflations performed during any procedure ranged 
from 1 to 10 (median 4). In most patients, arterial pressure 
was continuously monitored by a femoral artery catheter 
during the procedure and systemic arterial oxygen saturation 
was measured before and after the procedure. 
Patients were retrospectively classified into one of three 
groups. In 35 patients, follow-up angiography had been 
performed at 3 to 30 months (median 12) after balloon 
dilation. Twenty-four (69%) of these patients (group A) 
either had not undergone another palliative procedure or had 
had adequate palliation with repeat valvuloplasty. The other 
11 patients (31%) (group B) had required an aortopulmonary 
shunt at an interval of 0 to 3 months (median 1 month) after 
initial balloon dilation because of inadequate palliation. 
Thirty patients (group C) had not undergone repeat cardiac 
catheterization. The remaining two patients had had an 
aort0pulmonary shunt inserted before balloon dilation and 
were excluded from statistical analyses. 
Measurements. The maximal systolic diameter of the 
pulmonary anulus, of the right and left pulmonary arteries 
before the origin of their first branch at the hilum of the lung 
and of the descending aorta just above the level of the 
diaphragm at follow-up angiography was measured from 
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each angiogram. To calculate the actual diameter of the 
pulmonary valve anulus, the ratio of the measured anulus 
diameter to the diameter of the angiographic catheter (mea-
sured at the junction of the inferior vena cava and right 
atrium) was corrected for the known external diameter ofthe 
catheter. The ratio of the combined diameters of the right 
and left pulmonary arteries to that of the descending aorta 
was also calculated (21). To account for changes in the 
diameter of the pulmonary valve anulus over time, the 
percent change in the anulus diameter during the follow-up 
period was compared with normal data for the pediatric age 
group (22). 
Forty-two patients subsequently underwent total correc-
tion at 7 to 79 (median 33) months of age. In every case, the 
right ventricular outflow tract, pulmonary valve and main 
pulmonary artery were inspected for possible damage from 
the previous balloon valvuloplasty and these data are the 
subject of a separate report (23). 
Statistical analysis. Data analysis was conducted with use 
of the Statistical Analysis System (SAS), version 5.18. Each 
variable received a test for normality of distribution before 
any calculations were made. Many but not all variables had 
a non-Gaussian distribution. For this reason, descriptive 
statistics for all variables are presented as median values, 
with range for consistency. Continuous variables were re-
lated with either an unpaired t test or a rank sum Wilcoxon 
test for intergroup comparison or a paired t test or sign rank 
Wilcoxon test for intragroup comparisons, as distribution of 
the data dictated. Tests of association were made by chi-
square contingency analysis for categoric variables and the 
calculation of Pearson product moment or Spearman rho 
correlation coefficients for quantitative data. 
Event-free actuarial analysis was made according to the 
method of Kaplan and Meier (24). Homogeneity of event-
free rates was tested using the log-rank statistic. The eluci-
dation of risk factors for requireme,nt of a shunt and use of a 
transannular patch was made using stepwise multivariate 
logistic regression analysis. 
Probability (p) values < 0.05 were regarded as significant, 
whereas those between 0.05 and 0.1 were considered to 
indicate a possibly significant relation. Probability values 
>0.1 were judged to be nonsignificant. 
Results 
Immediate results of the procedure. Overall, 86 balloon 
valvuloplasty procedures were attempted in 67 patients. The 
criterion for repeat balloon valvuloplasty was an increase in 
the degree of cyanosis at follow-up study, as assessed 
clinically after successful balloon valvuloplasty. The pulmo-
nary valve could not be crossed at catheterization in three 
patients (including one patient in whom it could not be 
crossed at two separate catheterization procedures), and an 
aortopulmonary shunt was performed in all three. In two 
others whose pulmonary valve could not be crossed initially, 
balloon valvuloplasty was successfully performed at repeat 
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catheterization during the same hospital admission. The 
median screening time (as an indicator of the degree of 
radiation exposure) was 20 min (range 8 to 56) for patients 
aged < 1 year and 25 min (range 6 to 62) for those> 1 year. 
The median duration of follow-up study was 27.5 months 
(range 0.66 to 63). For the entire study group, the median 
balloon/anulus ratio was 1.5 (range 0.9 to 3.4). Systemic 
arterial oxygen saturation immediately after balloon dilation 
increased from 74% (range 46% to 99%) to 90.5% (range 45% 
to 100%). Both the absolute difference between pre- and 
postdilation values and the percent change in systemic 
oxygen saturation (median 14.5, range -33.8 to + 118.2) 
were highly significant (p < 0.001). Treatment with oral 
propranolol to prevent recurrent cyanotic spells was started 
o to 13 months (median 0.5 month) after balloon dilation in 17 
(25%) of the 67 patients. Propranolol therapy was continued 
in the 11 patients who were receiving it before the proce-
dure. In two patients, administration of propranolol was 
discontinued within 4 weeks after balloon valvuloplasty. 
Group A: balloon valvuloplasty only, with follow-up angi-
ography. Twenty-four patients had follow-up angiography 
11 months (range 3 to 27) after balloon dilation. The median 
age at balloon dilation was 4 months (range 0.26 to 52) and 
median balloonlanulus ratio was 1.68 (range 0.99 to 2.83). 
Systemic oxygen saturation after initial balloon dilation 
improved from 74% (range 56% to 99%) to 91% (range 69% 
to 100%) (p < 0.001). Ten patients had required treatment 
with oral propranolol for episodic cyanosis; their pulmonary 
stenosis however, was considered to be adequately dilated. 
At follow-up angiography, the pulmonary valve anulus had 
increased in diameter from 6.8 mm (range 3.6 to 14) before 
dilation to 10.6 mm (range 6 to 26.8) (p < 0.001) (Fig. 1). The 
percent change in the pulmonary anulus diameter (median 
55.1%, range - 3.8% to 281.2%) was greater than that which 
might have been expected over the same duration of 
follow-up (median 19.5%, range 5.3% to 41.4%) as a function 
of growth alone (p < 0.005) (22). The ratio of the combined 
right and left pulmonary artery diameters to that of the 
descending aorta increased from 1.9 (range 0.6 to 3.4) to 2.2 
(range 1.1 to 3.9) (p < 0.001). Seventeen of the 24 patients 
subsequently underwent surgical repair at a median age of23 
months (range 7 to 79), and there were no operative deaths. 
On comparing the subset of 10 patients with a balloon/ 
anulus ratio> 1.5 0.5 being the maximal recommended ratio 
[25,26] for dilation of isolated pulmonary valve stenosis) 
with the 10 who had a ratio < 1.5, the valve anulus increased 
from 5.4 (range 3.6 to 8.4) to 9.2 mm (range 6 to 23.1) in the 
group with the larger balloon/anulus ratio versus a change 
from 8 (range 6.7 to 14) to 11.7 mm (range 7.5 to 26.8) in the 
patients with the smaller ratio. There was no significant 
difference in the absolute change in diameter between the 
two subsets of patients, although the percent change tended 
to be higher for those with the larger balloon/anulus ratio 
(p<O.l). 
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Figure 1. Right ventricular angiograms in the same patient before 
(A) and 15 months after (B) balloon valvuloplasty, showing a clear 
increase in anulus diameter (arrowheads), which was significantly 
greater than that expected from growth alone. 
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Group B: balloon valvuloplasty and aortopuimonary shunt 
with foUow-up angiography. Eleven patients underwent an 
aortopulmonary shunt procedure 1 month (range 0 to 3 
months) after the balloon dilation procedure because of 
persistent symptoms. Of these, four patients had also re-
quired oral propranolol for recurrent episodic cyanosis after 
balloon dilation. The median age at balloon dilation was 3 
months (range 0.Q3 to 26) and balloon!anulus ratio was 1.6 
(range 0.9 to 2.6). Systemic arterial oxygen saturation 
changed from 67% (range 47% to 83%) to 76% (range 45% to 
97%) (p > 0.1). During a median follow-up period of 12 
months (range 8 to 30), the pulmonary anulus diameter 
changed from 5.9 mm (range 3.4 to 9.3) before dilation to 
9.7 mm (range 4.2 to 16.7) (p < 0.01). The percent change in 
pulmonary anulus diameter was 29.9% (range 8.1% to 
183.1%) compared with the expected 29% (range 5.6% to 
47.5%) due to growth alone (p > 0.1). The ratio of combined 
pulmonary artery diameters to descending aortic diameter 
increased from 1.7 (range 1.2 to 2.7) to 2.3 (range 1.6 to 3.2) 
(p < 0.005). Nine of the 11 patients had total correction at a 
median age of 39 months (range 25 to 52). There were two 
operative deaths. 
Group A versus group B. There were no significant 
differences between the two groups with respect to the 
/oilowing criteria: 1) age at initial balloon dilation; 2) balloon! 
anulus ratio; 3) diameter of the anulus before balloon dila-
tion; 4) ratio of the combined pulmonary artery diameters to 
descending aortic diameter before dilation or at follow-up 
angiography; and 5) interval between balloon dilation and 
follow-up angiography. 
Patients in group B had significantly lower systemic 
arterial oxygen saturation before balloon dilation than did 
patients in group A (p < 0.05). Balloon dilation also pro-
duced a significantly greater increase in oxygen saturation in 
patients judged to have had an adequate palliative procedure 
(group A) and who did not require a subsequent aortopul-
monary shunt (p < 0.001). However, no combination of 
variables before balloon dilation was able to significantly 
predict whether an individual patient would require an 
additional palliative procedure in the form of an aortopulmo-
nary shunt. When systemic oxygen saturation after dilation 
was added to the analysis it emerged as the only variable 
associated with predicting the likelihood of a shunt (p = 
0.02). Patients with a relatively low oxygen saturation after 
the balloon procedure had a greater probability of requiring 
a shunt than did those with a higher saturation. The interval 
between the balloon procedure and the next event (shunt, 
surgical correction or death) was also significantly reduced 
in group B patients (p < 0.001) (Fig. 2). 
The median change in pulmonary anulus diameter was 
greater than that expected/rom growth alone in both groups 
(Fig. 3), but the difference in group B was very small. Thus, 
dilation alone (group A) produced an anulus 35.6% larger 
than that expected from growth alone, whereas dilation 
followed by a shunt procedure (group B) produced a change 
of only 0.9% greater than that predicted by growth. 
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Figure 2. Graph showing the interval of freedom from the next 
event (shunt procedure, total repair or death) in group A (depicted 
as "no shunt") and group B ("shunt") after balloon valvuloplasty. 
Group B patients (n = 11) showed no significant improvement in 
systemic oxygen saturation after balloon dilation and had a median 
time to the next event (an aortopulmonary shunt) of 1 month. In 
contrast, group A patients (n = 24) had a significantly longer interval 
of freedom from the next event (p < 0.(01). 
For all group A patients, the balloonlanulus ratio corre-
lated significantly with change in pulmonary anulus diame-
ter (r = 0.60; p < 0.001) expressed as a percent of the 
predilation diameter. On considering the change in anulus 
diameter in the subgroups with a balloon!anulus ratio> 2 or 
<2 the subjective impression was one of a smaller, yet more 
consistent increase in diameter in those with a ratio <2 and 
a greater but increasingly unpredictable and inconsistent 
change in diameter in those with a ratio >2 (Fig. 4). 
However, correlation coefficients for these subsets of data 
were nonsignificant. Overall, 14 patients required treatment 
with oral propranolol after initial balloon dilation. Four of 
these 14 subsequently underwent an aortopulmonary shunt, 
after which propranolol was stopped in all 4. 
Figure 3. Scattergram of the balloonlanulus ratio (x axis) and the 
change in pulmonary anulus diameter (y axis) expressed as a percent 
of the original diameter. The percent change appears to be related to 
the balloonlanulus ratio up to a ratio of 2. The dotted line at 1.5 
represents the recommended balloonlanulus ratio for dilation of 
isolated pulmonary stenosis (see text). 
300 
~ 
':' 250 
~ 
E 200 
c 
~ 150 
::J 
:; 
§ 100 
.!: 
II> 50 
C> 
c 
• • . . ' . ... , 
• 
• 
• • 
• 
'I. 
•••• • 
~ Or---~~~r-~--.--------------­u • 
. ..! • 
-50+-----,-----~----_r-----.----~ 
0.5 1.0 1.5 2.0 2.5 3.0 
balloon: anulus ratio 
JACC Vol. 18, No.1 
July 1991: 159-65 
300 
• ~ 250 '-" .. 
Q) .... 
Q) 200 E 
0 
'iJ 150 • .. 
:3 •• :; 100 c: •••• 0 
.!: 50 -·:h··-Q) 
01 
c: • 
0 0 :. s:. 
u 
-50 
Observed 
• No Shunt 
·Shunt 
• 
• 
•• 
• -·~~!ih- _.A._ -.'U!.-.:. • 
Predicted Observed Predicted 
Figure 4. Scattergram of the observed and predicted changes in 
pulmonary anulus diameter for group A ("no shunt") and group B 
("shunt") patients. Group A patients showed a significantly greater 
percent change in anulus diameter than expected from growth alone. 
In comparison, the change in group B patients is negligible. 
Group C: balloon valvuloplasty only or balloon valvulo-
plasty and shunt, but no follow-up angiography. Thirty pa-
tients had not undergone another angiographic investigation 
after initial balloon dilation. Ofthese, three patients required 
treatment with oral propranolol after balloon valvuloplasty. 
During a follow-up period of 19.3 months (range 0.7 to 63), 7 
patients required an aortopulmonary shunt; 16 patients had 
total correction 28.5 months (range 11 to 57) after balloon 
valvuloplasty (1 of the 16 died at operation). Five other 
patients died during the follow-up period (see Mortality); the 
remaining two patients are in stable condition and awaiting 
corrective surgery. 
Complications. There were no deaths during or immedi-
ately after balloon valvuloplasty. A transient increase in 
cyanosis was seen during the procedure, and two patients 
received intravenous propranolol. Two patients who had no 
improvement in oxygen saturation received an aortopulmo-
nary shunt during the same hospital admission. One patient 
developed transient pulmonary edema several hours after 
the procedure and required temporary mechanical ventila-
tion. One patient developed group D streptococcal septice-
mia after catheterization and required intravenous antibiotic 
therapy. Two patients (both with a balloon/anulus ratio 
>2.5) developed cardiac tamponade and underwent emer-
gency surgical repair of the right ventricular outflow tract, 
followed by insertion of an aortopulmonary shunt in one 
patient. The incidence of these major and minor complica-
tions was similar to that reported (27) for other large series of 
catheter interventional procedures. 
Deaths. Overall, 8 (12%) of the 67 patients died during 
the follow-up period. There were three postoperative deaths 
associated with a low cardiac output. One patient in group B 
whose pulmonary valve could not be crossed at cardiac 
catheterization on two separate occasions died at home 
because of shunt failure 21 months after a shunt procedure. 
One patient who developed bacterial septicemia after bal-
loon dilation died at home 14 months later and at autopsy 
healed vegetations were seen on the tricuspid valve. Three 
SREERAM ET AL. 163 
BALLOON VALVULOPLASTY IN TETRALOGY OF FALLOT 
other patients died 5 days, 5 months and 7 months, respec-
tively, after balloon dilation. The first of these patients had 
tetralogy of Fallot with a complete A V septal defect and 
severe aortic valve stenosis and died suddenly in the hospi-
tal. The other two patients had mUltiple congenital abnor-
malities (velocardiofacial syndrome in one [velopharyngeal 
insufficiency, cleft palate, learning difficulties and a charac-
teristic facies] and VATER syndrome [a combination of 
vertebral, anal, tracheoesophageal, radial and renal anoma-
lies] with a complete AV septal defect in the other). At 
autopsy there was no evident damage to the right ventricular 
outflow tract as a result of previous balloon valvuloplasty. 
Corrective surgery. Forty-two patients have undergone 
total correction during the follow-up period. There were 
three early deaths (including one in a patient with an 
associated complete A V septal defect). Twenty-seven pa-
tients (64%) required transannular patch reconstruction of 
the right ventricular outflow tract, including six of the nine 
patients from group B who had had a palliative shunt and the 
two patients who had undergone an aortopulmonary shunt 
procedure before balloon dilation. Thus, there was no dif-
ference in the requirement for a trans annular patch between 
patients adequately treated by balloon dilation and those 
requiring a shunt. On logistic regression analysis, three 
variables were identified as potentially important predictors 
of the need for a transannular patch at subsequent repair. 
These were 1) a smaller anulus size at follow-up angiography 
(p = 0.07); 2) a lower pulmonary artery/aorta diameter ratio 
(p = 0.1); and 3) a higher balloon/anulus ratio at valvulo-
plasty (p = 0.08). 
Discussion 
Balloon dilation is now accepted as a safe and effective 
method for the treatment of congenital pulmonary stenosis 
(1-3). Stenosis at the pulmonary valve level is often an 
important cause of right ventricular outflow obstruction in 
tetralogy of Fallot, and balloon pulmonary valvuloplasty was 
performed as an alternative to an aortopulmonary shunt in 
patients who were believed to merit intervention on clinical 
grounds. The large variation in the balloon size (and there-
fore the balloon/anulus ratio) was due in part to the limited 
number of balloon sizes available for use in the early part of 
this experience and to the inaccuracy in measuring the 
anulus diameter at catheterization. 
Group A and group B. Preliminary results of balloon 
valvuloplasty reported from this institution (4) suggested an 
immediate improvement in systemic arterial oxygen satura-
tion, a shorter hospital stay and avoidance of a shunt 
procedure. Although patients were not randomized before 
initial intervention to directly compare the results of balloon 
dilation and a shunt procedure, two such groups became 
available for comparison because some patients in whom 
balloon valvuloplasty failed to produce sustained clinical 
improvement received an aortopulmonary shunt. In those 
patients who required a palliative shunt (group B), the 
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interval between balloon valvuloplasty and the shunt proce-
dure was also sufficiently short (Fig. 2) that changes seen at 
follow-up angiography may be reasonably attributed to the 
effects of the shunt. 
Changes in pulmonary anulus diameter. Ideally, any 
comparisons of changes in pulmonary anulus diameter at 
follow-up angiography should be made against serial angio-
graphic data on unoperated patients with tetralogy of Fallot. 
However, this was not possible because all patients in this 
series were symptomatic and required intervention. The 
change in pulmonary anulus diameter during the follow-up 
period was therefore compared with that expected from 
growth alone, using data obtained from postmortem exami-
nation of children who had died from noncardiac events (22). 
Because of difficulties in making quantitative comparisons 
between formalin-fixed postmortem specimens and their 
equivalents in life, changes in the pUlmonary anulus between 
initial balloon valvuloplasty and follow-up angiography were 
expressed as a percent of the original anulus diameter. The 
better technical result in the patients not requiring a shunt 
procedure (group A), as evidenced by a significant elevation 
in oxygen saturation immediately after dilation, was perpet-
uated at follow-up angiography in an anulus much larger than 
could be achieved by growth alone. After a shunt procedure, 
the anulus diameter did increase to a size just larger than 
expected, but the change was negligible compared with a 
technically satisfactory balloon dilation. Growth of the pul-
monary arteries, expressed as the ratio of the combined 
pUlmonary artery diameters to that of the descending aorta, 
was comparable in the two groups, reflecting the increase in 
pulmonary blood flow produced by a technically satisfactory 
balloon dilation or shunt procedure. 
Primary repair in infancy versus staged correction. Pri-
mary total correction of tetralogy of Fallot in infancy is now 
being performed in some centers (10,11), with an acceptable 
operative mortality rate. Although the early results after 
correction in infants have been encouraging, there are lim-
ited long-term follow-up studies (16) of the hemodynamic 
and functional status. Correction in infants usually involves 
the placement of a transannular patch in the right ventricular 
outflow tract. In the earlier surgical series (15), this was an 
additional risk factor for total correction in infancy, although 
more recent experience (10,11) does not suggest a higher 
operative mortality rate. Insertion of a trans annular patch 
inevitably produces pulmonary regurgitation. In the largest 
reported series of primary repair in infancy (16), pulmonary 
valve incompetence was present in 89% of patients with a 
transannular patch or nonvalved right ventricle to pulmo-
nary artery conduit. Although none of these patients had 
required pulmonary valve replacement during a mean 
follow-up period of 60 months, 18% of these patients had at 
least a moderate degree of cardiomegaly on a late chest 
X-ray study, presumably related to chronic pulmonary in-
sufficiency. Although pulmonary regurgitation appears to be 
well tolerated clinically in the short or medium term, several 
JACC Vol. 18. No. I 
July 1991:159-65 
studies (17-19) have illustrated its long-term deleterious 
effect on right ventricular performance. 
Staged surgical repair therefore continues to be used as 
an alternative to primary correction, particularly in patients 
with a small pulmonary anulus and pulmonary arteries and 
other associated risk factors such as a complete A V septal 
defect. Although an aort0pulmonary shunt can be inserted 
with a low mortality rate and may reduce the necessity for a 
transannular patch, there is a small but definite incidence of 
shunt failure requiring reoperation (8) and of complications 
such as distortion of the pulmonary arteries or pulmonary 
hypertension (13,14). In some of these patients, balloon 
dilation of the pulmonary valve may be a suitable alternative 
to an aortopulmonary shunt. 
In retrospect, however, it was not possible to predict 
before intervention which patients might benefit maximally 
from balloon dilation. This observation may reflect the wide 
morphologic variability of the right ventricular outflow tract, 
pulmonary valve and pulmonary arteries in patients with 
tetralogy of Fallot. 
Role of infundibular stenosis. Even when it was effective 
in relieving obstruction at the valve level and diminishing 
cyanosis, balloon valvuloplasty did not always prevent sub-
sequent cyanotic spells, although these were well controlled 
with oral propranolol. Such spells may be attributed to 
dynamic infundibular stenosis. However, infundibular ste-
nosis was very difficult to quantify and assessment of its 
severity in terms of the length of the infundibular septum, its 
thickness in systole or the minimal systolic diameter of the 
right ventricular outflow tract did not correlate with the 
clinical status after balloon valvuloplasty. 
Although a significant proportion of patients required a 
transannular patch at surgical correction, there was no 
difference between patients who had required a shunt and 
those who had undergone palliation by balloon dilation alone 
for this event. For both groups, the use of a transannular 
patch was associated with a smaller valve anulus and pul-
monary arteries. 
Mortality. Of the eight deaths in the series, only one (in 
the patient with vegetations on the tricuspid valve at au-
topsy) might be attributed to the effects of balloon dilation, 
although this death was a late event (14 months later). None 
of the three operative deaths were related to the effects of 
previous balloon dilation. In the unoperated patients, two 
had multiple congenital anomalies and in two there was a 
complete A V septal defect in addition to tetralogy of Fallot. 
Conclusions. Balloon dilation of the pulmonary valve is a 
relatively safe procedure and appears to produce adequate 
palliation in most patients with tetralogy of Fallot, while 
promoting growth of the pulmonary anulus and branch 
pulmonary arteries. In view of the possible damaging effects 
of large balloons and the less consistent relation between 
changes in anulus diameter and a larger balloonlanulus ratio, 
the maximal balloon/anulus ratio should not be >2. Finally, 
balloon pulmonary valvuloplasty is a useful alternative to an 
aortopulmonary shunt and may allow later total correction in 
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some patients with poorly developed pulmonary arteries or 
with associated complex intracardiac defects. Failure to 
achieve an immediate increase in systemic arterial oxygen 
saturation of ~10% over the pre valvuloplasty level may be 
an indication for an aortopulmonary shunt. 
We thank Jean Beamer and Christine Daniels for their assistance in retrieving 
the data. 
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